Monoclonal antibodies for Borrelia burgdorferi detection

Monoclonal antibodies for Borrelia burgdorferi detection are essential tools in diagnosing Lyme disease with high specificity and sensitivity. These antibodies target specific antigens, such as OspA, enabling accurate identification of the pathogen in clinical samples. Their use in immunoassays and diagnostic kits improves early detection and treatment outcomes. Monoclonal antibodies also support research efforts to understand Borrelia burgdorferi biology and develop effective therapeutic strategies against Lyme disease.